CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock OTC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale President and CEO sold 3,805 shares at $3.35 ($12,753)
- 4 Planned sale EVP & Chief Medical Officer sold 6,770 shares at an average $4.05 ($27,416)
- 4 Planned sale President and CEO sold 3,497 shares at $3.97 ($13,883)
- 4 Open-market sale President and CEO sold 3,506 shares at $3.16 ($11,079)
- 4 Grant or award EVP & Chief Medical Officer acquired 100,000 shares (grant or award)
- 4 Grant or award EVP, Chief Development Officer acquired 95,000 shares (grant or award)
- 4 Open-market sale SVP, Chief Business Officer sold 6,357 shares at $3.03 ($19,257)
- 4 Open-market sale SVP, General Counsel&Secretary sold 6,878 shares at $3.03 ($20,835)
- 4 Open-market sale EVP & Chief Commercial Officer sold 11,239 shares at $3.03 ($34,045)
- 4 Open-market sale EVP, CFO & Treasurer sold 11,205 shares at $3.03 ($33,942)
- 4 Open-market sale President and CEO sold 33,033 shares at $3.03 ($100,064)
- 4 Open-market sale EVP, CFO & Treasurer sold 2,802 shares at $3.04 ($8,509)
- 4 Open-market sale EVP, Chief Development Officer sold 5,869 shares at an average $3.19 ($18,717)
Page 8 of 31 · 601 filings